Intolerance to acetylsalicylic acid (aspirin) and tartrazine. Evidence of complement activation in a patient following oral challenge with tartrazine.
D000284:Administration, Oral; D000707:Anaphylaxis / Q000139:chemically induced* / Q000175:diagnosis; D001241:Aspirin / Q000009:adverse effects*; D001391:Azo Compounds / Q000009:adverse effects*; D003176:Complement C3 / Q000276:immunology; D003171:Complement Pathway, Classical / Q000187:drug effects; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D013645:Tartrazine / Q000008:administration & dosage / Q000009:adverse effects*
D001391:Azo Compounds; D003176:Complement C3; D013645:Tartrazine; D001241:Aspirin